Decision: Favourable
Study Title:
A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus Placebo in Combination With Paclitaxel With or Without Bevacizumab for the Treatment of Platinum-resistant Recurrent Ovarian Cancer (KEYNOTE-B96 / ENGOT-ov65)
NREC Code:
21-NREC-CT-134
Decision:
Favourable
Meeting Date:
17/11/2021
Study Type:
CT application
Principal Investigator:
Dr Dearbhaile Collins
PI Institution:
Cork University Hospital
Sponsor:
MSD